BPC-157 vs Ipamorelin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

BPC-157

Body Protection Compound-157 is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable healing properties in research studies.

Full details →

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that stimulates the release of growth hormone from the pituitary gland without significantly affecting cortisol or prolactin.

Full details →

Side-by-Side Comparison

Aspect	BPC-157	Ipamorelin
Dose Range	250 mcg–500 mcg	100 mcg–300 mcg
Frequency	2x daily	2x daily
Cycle Length	4–6 weeks	8–12 weeks
Route	subcutaneous	subcutaneous
Mechanism	BPC-157 works through multiple pathways including upregulation of growth factor expression, nitric oxide system modulation, and promotion of angiogenesis. It enhances tendon-to-bone healing and supports the formation of new blood vessels.	Acts as a ghrelin mimetic, binding to the ghrelin receptor (GHS-R) in the pituitary to stimulate GH release. Highly selective with minimal effect on other hormones.
Typical Dosage	Typical research dosages range from 250-500mcg administered 1-2 times daily. Both subcutaneous and oral administration have been studied.	Typical dosing ranges from 200-300mcg administered 2-3 times daily, often combined with CJC-1295.
Administration	Can be administered subcutaneously near the injury site or systemically. Stable in gastric juice, making oral administration viable.	Subcutaneous injection. Best results when administered fasted or before sleep. Often stacked with GHRH peptides.
Side Effects	Generally well-tolerated in research. Some reports of mild nausea or dizziness at higher doses.	Generally well-tolerated. May cause mild headaches, lightheadedness, or increased hunger initially.
Best For	Muscle Growth Recovery & Healing	Muscle Growth Fat Loss Recovery & Healing Sleep Quality